EU judges prescribe smaller fine for Servier following “pay-for-delay” appeal
On 12 December 2018 the European General Court partially overturned a 2014 European Commission decision fining Servier and six generic pharmaceutical firms for abuse of dominance and/or involvement in illegal “pay-for-delay” agreements, whilst confirming that certain “pay-for-delay” agreements are restrictions of competition by object.
Also in this newsletter
UK’s CMA publishes Final Report in Investment Consultants Market Investigation
ECN+ Directive: Council of the EU adopts law boosting EU antitrust regulators’ powers
China’s SAMR fines three glacial acetic acid suppliers RMB 6.25m for price collusion and confiscates illegal gains of RMB 6.58m
